While FDA approvals for potentially breakthrough treatments for Covid-19 languish, many wonder if recent plans from the Biden administration to control the distribution of monoclonal antibodies are a plan to hold back Covid-19 treatments in order to force Americans to get vaccinated.
A. Benjamin Mannes